LAURA INGRAHAM (HOST): Hydroxychloroquine, chloroquine, [Remdesivir], I mean, all of these different antivirals have been shown fairly promising in some of the early trials, some of them in vitro -- are those the type of antivirals for the treatment, not the vaccine, that you all are looking at?
DR. ANTHONY FAUCI (NATIONAL INSTITUTES OF HEALTH): Yes. We have to be careful, Laura, that we don't assume something works based on an anecdotal report that's not controlled. And I refer specifically to hydroxychloroquine. There's a lot of buzz out there on the internet, on the social media about that.
INGRAHAM: Oh, there have been studies published, though, right?
FAUCI: Well, you know those studies, some of them were not controlled. But what we're going to do, Secretary Azar, the Ssecretary of HHS, has asked me at the NIH, Bob Redfield at CDC, Steve Hahn at FDA to take a look at all that data, analyze it, and make some decision what the best way forward. More clinical trials, not we'll see, but we're going to look at that data very seriously.